Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Sep
5
2023
 Unpacking Averages: How Accurate Do Class II Medical Devices Need to Be to Obtain 510(k) Clearance? Epstein Becker & Green, P.C.
Sep
5
2023
 FDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors Epstein Becker & Green, P.C.
Sep
5
2023
 State Regulation of Pharmacy Benefit Managers: Tenth Circuit Holds That ERISA and Medicare Part D Preempt Key Parts of Oklahoma PBM Law Epstein Becker & Green, P.C.
Sep
1
2023
 CMS Names Its First Ten Negotiated Part D Drugs: Inflation Reduction Act Updates Epstein Becker & Green, P.C.
Sep
1
2023
 Seventh Circuit Follows Illinois Supreme Court Precedent and Finds BIPA Claims Timely Vedder Price
Sep
1
2023
 Reclassifying Cannabis as a Schedule III Substance – Will the DEA Agree? Sheppard, Mullin, Richter & Hampton LLP
Sep
1
2023
 Kraft Heinz Agrees to Settle Suit Over Malic Acid Flavoring Keller and Heckman LLP
Sep
1
2023
 Alabama Medical Cannabis Licensing Program Halted (Again): Is the Levee Goin’ to Break? Bradley Arant Boult Cummings LLP
Sep
1
2023
 Medical Supplier Agrees to Pay $29 Million for FCA Violations ArentFox Schiff LLP
Aug
31
2023
 Two New Drug Supply Chain Security Act Guidance to Help Pharmaceutical Supply Chain Partners Comply with the DSCSA’s Move to Electronic Tracking Nelson Mullins
Aug
31
2023
 FDA Issues Warning Letters to Three Infant Formula Manufacturers Keller and Heckman LLP
Aug
31
2023
 Does the End Justify the Means? Privacy Advocates React to the Cooper Davis Act Bradley Arant Boult Cummings LLP
Aug
31
2023
 Smoke ‘Em if You Got ‘Em (OK, Not Just Yet): Feds Recommend Rescheduling Marijuana Bradley Arant Boult Cummings LLP
Aug
31
2023
 No Two Ways About It: No Disparagement ≠ Teaching Away, Free Samples ≠ Commercial Success McDermott Will & Emery
Aug
31
2023
 Alert: US DHHS Recommends Moving Cannabis to Schedule III Womble Bond Dickinson (US) LLP
Aug
31
2023
 PFAS AFFF MDL Settlements Moving Forward CMBG3 Law
Aug
31
2023
 Aspartame Safety Review by the WHO: a Short Story about a Tempest in a Teapot… Keller and Heckman LLP
Aug
30
2023
 Demand Heats Up for Biochar Carbon Projects Beveridge & Diamond PC
Aug
30
2023
 Largest U.S. E-Cigarette Clinical Trial Confirms Role in Smoking Cessation Keller and Heckman LLP
Aug
29
2023
 FDA Signs Regulatory Partnership Arrangement with Ecuador Covering Shrimp Imports Keller and Heckman LLP
Aug
28
2023
 Expert Testimony Rejected in California Heavy Metals Baby Food Lawsuit Keller and Heckman LLP
Aug
28
2023
 TTB Issues Updated Guidance on Transfers of Beer Between Breweries Under Separate Ownership McDermott Will & Emery
Aug
25
2023
 FDA’s Office of Prescription Drug Promotion Issues Second Untitled Letter of the Year to Exeltis for Misleading Statements Relating to SLYND® Sheppard, Mullin, Richter & Hampton LLP
Aug
25
2023
 FDA Proposes to Amend Canned Tuna Standard Keller and Heckman LLP
Aug
25
2023
 The Generative AI Revolution: Key Legal Considerations for the Cannabis Industry ArentFox Schiff LLP
Aug
24
2023
 China Bans Seafood from Japan Keller and Heckman LLP
Aug
24
2023
 How to Introduce Alternative Proteins via Tasting Trials in the Netherlands and Singapore Keller and Heckman LLP
Aug
24
2023
 New York Cannabis Lawsuit Overview and Possible Effects on the Much-Anticipated Adult-Use Cannabis License Application Period Epstein Becker & Green, P.C.
Displaying 1429 - 1456 of 11745
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins